Insights

International Expansion Acurable has successfully launched its AcuPebble SA100 product in the UK, Spain, and Europe, with plans to expand into North America. This presents a significant sales opportunity for establishing partnerships with healthcare organizations in new markets.

Funding Momentum With recent investments totaling $11M, Acurable is well-positioned to scale its operations and product offerings. Sales representatives can leverage this financial backing to negotiate larger orders and contracts with potential clients.

Industry Partnerships Collaborations with companies like Nyxoah SA indicate Acurable's commitment to strategic partnerships to expand market reach. Sales professionals can explore partnership opportunities with complementary medical technology firms to access new customer segments.

Regulatory Approvals AcuPebble SA100 obtained both the CE mark in Europe and FDA clearance in the US, demonstrating compliance with stringent regulatory requirements. This can be highlighted during sales pitches to reassure potential clients of product quality and market readiness.

Product Innovation The innovative technology developed by Acurable offers a breakthrough in respiratory medicine, addressing conditions like obstructive sleep apnoea. Sales teams can emphasize the unique selling points of Acurable's products to differentiate themselves in the competitive medical equipment manufacturing industry.

Acurable Tech Stack

Acurable uses 8 technology products and services including Osano, Atlassian Jira, React, and more. Explore Acurable's tech stack below.

  • Osano
    Cookie Compliance
  • Atlassian Jira
    Issue Trackers
  • React
    Javascript Frameworks
  • Redux
    Javascript Frameworks
  • Emotion
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • Animate.css
    UI Frameworks
  • Adobe Creative Suite
    Visualisation Software

Media & News

Acurable's Email Address Formats

Acurable uses at least 1 format(s):
Acurable Email FormatsExamplePercentage
First@acurable.comJohn@acurable.com
39%
Last@acurable.comDoe@acurable.com
13%
First.Last@acurable.comJohn.Doe@acurable.com
9%
First@acurable.comJohn@acurable.com
39%

Frequently Asked Questions

Where is Acurable's headquarters located?

Minus sign iconPlus sign icon
Acurable's main headquarters is located at London, GB. The company has employees across 2 continents, including EuropeOceania.

What is Acurable's official website and social media links?

Minus sign iconPlus sign icon
Acurable's official website is acurable.com and has social profiles on LinkedIn.

What is Acurable's NAICS code?

Minus sign iconPlus sign icon
Acurable's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Acurable have currently?

Minus sign iconPlus sign icon
As of May 2024, Acurable has approximately 32 employees across 2 continents, including EuropeOceania. Key team members include Head Of Engineering And Co-Founder: A. I.Head Of Platform: D. C. R.Founder: E. R.. Explore Acurable's employee directory with LeadIQ.

What industry does Acurable belong to?

Minus sign iconPlus sign icon
Acurable operates in the Medical Equipment Manufacturing industry.

What technology does Acurable use?

Minus sign iconPlus sign icon
Acurable's tech stack includes OsanoAtlassian JiraReactReduxEmotionOpen GraphAnimate.cssAdobe Creative Suite.

What is Acurable's email format?

Minus sign iconPlus sign icon
Acurable's email format typically follows the pattern of . Find more Acurable email formats with LeadIQ.

How much funding has Acurable raised to date?

Minus sign iconPlus sign icon
As of May 2024, Acurable has raised $11M in funding. The last funding round occurred on Oct 03, 2022 for $11M.

When was Acurable founded?

Minus sign iconPlus sign icon
Acurable was founded in 2016.
Acurable

Acurable

Medical Equipment ManufacturingLondon, United Kingdom11-50 Employees

Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home.

Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas, and has been recognised as a breakthrough in respiratory medicine, winning some of the most respected awards in the industry, among them an XPrize and several Innovate UK grants. It has also featured in national and international media, including earlier this year in the BBC Horizon documentary How to Sleep Well with Michael Mosley.

In 2020 our first product, AcuPebble SA100, became the first medical device in the world to obtain the CE mark for the automated diagnosis of obstructive sleep apnoea at home, and a few months later the product gained FDA clearance for home sleep apnoea testing in the US. AcuPebble SA100 is now in use within healthcare organisations across the UK and Europe, and will be launching in the USA in the coming months. At the same time we continue our research to develop new products that will fundamentally improve the lives of millions of people suffering from serious chronic conditions such as COPD, Asthma and Epilepsy.

Section iconCompany Overview

Headquarters
London, GB
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $11M

    Acurable has raised a total of $11M of funding over 3 rounds. Their latest funding round was raised on Oct 03, 2022 in the amount of $11M.

Section iconFunding & Financials

  • $11M

    Acurable has raised a total of $11M of funding over 3 rounds. Their latest funding round was raised on Oct 03, 2022 in the amount of $11M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.